abstract |
The present invention relates to cyclic ureas of the compounds of formula (I), which are suitable for use as inhibitors of metalloproteases, in particular ADAMTS proteases and TNF-α converting enzymes. The invention also relates to methods for producing these compounds and their use to treat diseases such as osteoarthritis and rheumatoid arthritis. [Chemical 1] |